Grant · European Commission
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Official page- Type
- Grant
- Organisation
- European Commission
- Location
- European Union
- Deadline
- 16 September 2027
- Posted
- 10 February 2027
About this listing
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Last checked 5 October 2026. Found via EU Funding & Tenders: open calls.